Olmesartan Medoxomil BP

Composition : Olmesartan Medoxomil 20 mg Tablet.

Indication : Olmesartan Medoxomil is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.

Dosage and administration : Olmetic : Adults: Dosage must be individualized. The usual recommended starting dose of Olmesartan Medoxomil is 10 to 20 mg once daily when used as monotherapy. For patients requiring further reduction in blood pressure after 2 weeks of therapy, the dose of Olmesartan Medoxomil may be increased to 20 to 40 mg. Maximum recommended daily dose is 40mg. Elderly and renal impairment: The maximum dose in elderly and patients with mild to moderate renal impairment is 20mg daily. Children and adolescents: The safety and efficacy have not been established in children and adolescents up to 18 years of age. Patients with Hepatic Impairment : No dosage adjustment is necessary with hepatic impairment. Or, as directed by the registered physicians.

Use in pregnancy and lactation : Pregnancy Categories C (first trimester) and D (second and third trimesters). It is not known whether Olmesartan Medoxomil is excreted in human milk. Mothers must not breast-feed if they are taking Olmesartan Medoxomil. Drugs that act directly on the renin-angiotensin system can cause fetal and neonatal morbidity and death when administered to pregnant women. When pregnancy is detected, this drug should be discontinued as soon as possible.

Packing : Olmetic : 3 x 14's tablets in blister pack.

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2023 Designed and Developed by ATI Limited.